Related Experiment Video
Updated: Jun 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Limited distribution of a cardiomyopathy-associated variant in India
Tatum S Simonson1, Yuhua Zhang, Chad D Huff
1Department of Human Genetics, University of Utah, Salt Lake City, Utah 84112, USA.
Insights
A specific MYBPC3 gene deletion linked to cardiomyopathy is prevalent in Indian populations, with frequencies over 8% in some groups. This genetic variant was not found in populations sampled outside of India, indicating a localized distribution.
Area of Science:
- Cardiovascular Genetics
- Population Genetics
- Molecular Cardiology
Background:
- Heart failure is a significant cause of mortality in South Asia, with cardiomyopathy being a primary contributor.
- Myosin binding protein C (MYBPC3) plays a crucial role in cardiac muscle function and structural integrity.
- Mutations in MYBPC3, including a specific deletion, are linked to familial hypertrophic or dilated cardiomyopathies.
Purpose of the Study:
- To investigate the frequency and distribution of a specific 25-base-pair deletion in the MYBPC3 gene.
- To determine if this deletion is present in populations outside of South Asia.
- To understand the population genetics of this MYBPC3 variant within India.
Main Methods:
- Genotyping of 447 individuals across 19 populations, with a focus on 10 Indian populations and neighboring regions (Pakistan, Nepal).
- Analysis of a known 25-base-pair deletion in intron 32 of the MYBPC3 gene.
- Comparison of deletion frequencies with existing population variation data and SNP chip data.
Main Results:
- The MYBPC3 deletion was found at frequencies exceeding 8% in some Indian populations.
- The deletion was absent in all sampled populations outside of India.
- Observed variations in deletion frequencies among Indian populations align with known genome-wide patterns.
Conclusions:
- The MYBPC3 intron 32 deletion is primarily prevalent in Indian populations.
- The distribution pattern of this variant is consistent with broader genomic variation trends within India.
- This finding aids in understanding the genetic basis of cardiomyopathy in South Asia.
Abstract:
Heart failure is a leading cause of death of people in South Asia, and cardiomyopathy is a major cause of heart failure. Myosin binding protein C (MYBPC3) is expressed in the heart muscle, where it regulates the cardiac response to adrenergic stimulation and is important for the structural integrity of the sarcomere. Mutations in the MYBPC3 gene are associated with hypertrophic or dilated cardiomyopathies. A 25-base-pair deletion in intron 32 causes skipping of the downstream exon and is associated with familial cardiomyopathy. To date, this deletion is found primarily in India and South Asia, although it is also found at low frequency in Southeast Asia. In order to better characterise the distribution of this variant, we determined its frequency in 447 individuals from 19 populations, including 10 populations from India and neighbouring populations from Pakistan and Nepal. The deletion frequency is over 8% in some of our Indian samples, and it is not present in any of the populations we sampled outside of India. The differences in the deletion frequencies among populations in India are consistent with patterns of variation previously reported and with patterns we observed among Indian populations based on high-density SNP chip data. Our results indicate that the MYBPC3 deletion is primarily found among Indian populations and that its distribution is consistent with genome-wide patterns of variation in India.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Animal Mitochondrial Genetics
Principles of Pharmacogenetics: Types of Genetic Variants